ALPS Medical Breakthroug... Share Price

-0.07 (-0.2%)
Upgrade to Real-Time
Regular Market
Volume 28,435
Bid Price
Ask Price
News -
Day High 34.66


52 Week Range


Day Low 33.2196
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Etf Ticker Symbol Market Type
ALPS Medical Breakthroughs ETF SBIO AMEX Exchange Traded Fund
  Price Change Change Percent Etf Price Last Traded
-0.07 -0.2% 34.30 15:07:39
Open Price Low Price High Price Close Price Prev Close
33.88 33.2196 34.66 34.37
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
240 28,435  33.66  957,036 - 31.961 - 64.04
Last Trade Time Type Quantity Etf Price Currency
15:07:39 100  34.30 USD


Draw Mode:

ALPS Medical Breakthroughs ETF Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 145.78M 4.25M 4.25M  -  - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News ALPS Medical Breakthroug...

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

SBIO Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week37.4037.4031.96134.6441,252-3.10-8.29%
1 Month43.3244.2231.96138.1029,258-9.02-20.82%
3 Months47.3549.6431.96141.3725,983-13.05-27.56%
6 Months45.6449.6431.96142.9619,427-11.34-24.85%
1 Year56.5064.0431.96148.2624,465-22.20-39.29%
3 Years31.5864.0425.1040.7435,4872.728.61%
5 Years23.0064.0422.1236.8041,57511.3049.13%

The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network® Medical Breakthroughs Index. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Your Recent History
ALPS Medic..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220125 20:22:47